{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:45:27Z","timestamp":1792651527631,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Hyper-IgE Syndrome (HIES) is a rare inborn error of immunity (IEI) characterized by a constellation of symptoms related to susceptibility to\n                    <jats:italic>Staphylococcal<\/jats:italic>\n                    skin and pulmonary infections, eczema, raised serum IgE (&amp;gt;2,000 IU\/ml), craniofacial anomalies, and recurrent bone fractures. Data on HIES from the Indian subcontinent is scarce and restricted to small case series and case reports. This is the first compilation of national data on HIES.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and Methods:<\/jats:bold>\n                    A total 103 cases clinically diagnosed and treated as HIES were analyzed from nine centers. Cases with clinical and\/or molecular diagnosis of DOCK8 deficiency were not included. Patients were divided into two groups: group I for whom a heterozygous rare variant of STAT3 was identified, and group II, with clinical features similar to those of AD STAT3 deficiency, but without any genetic diagnosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Genetic diagnosis was available in 27 patients (26.2%) and all harbored rare variants in the STAT3 gene. Majority of these STAT3 HIES patients presented with recurrent skin abscesses (77.7%) or pneumonia (62.9%) or both (59.2%). Other features included eczema (37%), candidiasis (55.5%), facial dysmorphism (55.5%), recurrent fractures (11.1%), and retained primary teeth (7.4%).\n                    <jats:italic>Mycobacterial<\/jats:italic>\n                    infections were seen in a significant 18.5%. Mortality was seen in three subjects (11.1%). A similar trend in the clinical presentation was observed when all the 103 patients were analyzed together. Twenty percent of patients without a rare variant in the STAT3 gene had an NIH score of \u226540, whereas, 51.9% of STAT3 HIES subjects had scores below the cut off of \u226540. TH17 cell numbers were low in 10\/11 (90.9%) STAT3 HIES tested. Rare variants observed were 8 in exon 21; 8 in exon 13; 3 in exon 10; 2 in exon 15, and one each in exon 6, 16, 17, 19, 22, and splice site downstream of exon 12. Seven variants were novel and included F174S, N567D, L404Sfs\n                    <jats:sup>*<\/jats:sup>\n                    8, G419 =, M329K, T714I, R518X, and a splice site variant downstream of exon 12.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    The report includes seven novel STAT3 variants, including a rare linker domain nonsense variant and a CC domain variant.\n                    <jats:italic>Mycobacterial<\/jats:italic>\n                    diseases were more frequent, compared to western literature.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.626593","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:25:02Z","timestamp":1614299102000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical Profile of Hyper-IgE Syndrome in India"],"prefix":"10.3389","volume":"12","author":[{"given":"Biman","family":"Saikia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana W.","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Pandiarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smrity","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad D.","family":"Taur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambreen","family":"Pandrowala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Gowri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetika Mallik","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha Prasada","family":"Lashkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Uppuluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateswaran V.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Bhattad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Cyril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Govindaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT 3 mutation in the hyper Ig E syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT 3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature."},{"key":"B3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e20191804","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J Exp Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am J Hum Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mgg3.28","article-title":"Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzonlike craniosynostosis","volume":"1","author":"Keupp","year":"2013","journal-title":"Mol Genet Genomic Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J Exp Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"eaat4956","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A recessive form of Hyper IgE Syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"B\u00e9ziat","year":"2018","journal-title":"Sci Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"eaat4941","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ng.3898","article-title":"Germline hypomorphic CARD11 mutations in severe atopic disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00335-018-9767-2","article-title":"Human Hyper-IgE syndrome: singular or plural","volume":"29","author":"Zhang","year":"2018","journal-title":"Mamm Genome."},{"key":"B16","first-page":"328","article-title":"Hyperimmunoglobulin E Syndrome","volume":"31","author":"Pherwani","year":"1994","journal-title":"Indian Paediatr."},{"key":"B17","first-page":"827","article-title":"Hyperimmunoglobulin E syndrome","volume":"34","author":"Salaria","year":"1997","journal-title":"Indian Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02728870","article-title":"Hyper immunoglobulin E syndrome","volume":"68","author":"Salaria","year":"2001","journal-title":"Indian J Pediatr."},{"key":"B19","first-page":"1029","article-title":"Hyper immunoglobulin E syndrome","volume":"38","author":"Pherwani","year":"2001","journal-title":"Indian Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/ijpd.IJPD_144_16","article-title":"Unusual presentations and associations of hyper IgE Syndrome: retrospective analysis of ten cases at tertiary care institute - With review of indian published reports","volume":"19","author":"Patel","year":"2018","journal-title":"Indian J Paediatr Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.12932\/AP0456.32.4.2014","article-title":"Hyper-IgE syndrome with a novel STAT3 mutation- a single center study from India","volume":"32","author":"Saikia","year":"2014","journal-title":"Asian Pac L Allergy Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12098-017-2336-y","article-title":"Novel mutation in SH2 domain of STAT3 (p.M660T) in Hyper-IgE Syndrome with sterno-clavicular and paravertebral abscesses","volume":"84","author":"Saikia","year":"2017","journal-title":"Indian J Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s12098-016-2150-y","article-title":"TH17 cells in STAT3 related Hyper-IgE Syndrome","volume":"83","author":"Sharma","year":"2016","journal-title":"Indian J Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3389\/fimmu.2018.01080","article-title":"STAT3 mediated transcriptional regulation of Osteopontin in STAT3 Loss-of-function related Hyper IgE Syndrome","volume":"9","author":"Goel","year":"2018","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12098-017-2603-y","article-title":"Rapid transition of facial features from early to mid- adolescence in Autosomal Dominant Hyper IgE Syndrome with STAT3 variation","volume":"85","author":"Govindaraj","year":"2018","journal-title":"Inadian J Paediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1749-6632.2011.06353.x","article-title":"Primary immunodeficiencies in India: a perspective","volume":"1250","author":"Gupta","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","article-title":"Autosomal dominant hyper-IgE syndrome in the USIDNET registry","volume":"6","author":"Gernez","year":"2017","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome molecular, cellular, and clinical features from a French National Survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10875-017-0369-7","article-title":"Clinical manifestations and genetic analysis of 17 patients with autosomal dominant hyper-IgE syndrome in mainland china: new reports and a literature review","volume":"37","author":"Wu","year":"2017","journal-title":"J Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12885","DOI":"10.1111\/sji.12885","article-title":"Autosomal dominant hyper IgE syndrome from single centre in Chongqing, China (2009-2018)","volume":"91","author":"Xiang","year":"2020","journal-title":"Scand Hum Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","article-title":"Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome","volume":"125","author":"Woellner","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jfma.2011.11.004","article-title":"Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs)","volume":"110","author":"Lee","year":"2011","journal-title":"J Formos Med Assoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1651-2227.1998.tb01535.x","article-title":"Disseminated bacillus Calmette-Gu\u00e9rin infection in a girl with hyperimmunoglobulin E syndrome","volume":"87","author":"Pasic","year":"1998","journal-title":"Acta Paediatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jaci.2009.01.068","article-title":"A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome","volume":"123","author":"Kim","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1869524","DOI":"10.1155\/2019\/1869524","article-title":"Evidence that a STAT3 mutation causing hyper IgE syndrome leads to repression of transcriptional activity","volume":"2019","author":"Bahal","year":"2019","journal-title":"Case Rep Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.jaip.2019.02.012","article-title":"Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and\/or neonatal rash: evidence from the Italian cohort of 61 patients with elevated IgE","volume":"7","author":"Lorenzini","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jaci.2018.05.009","article-title":"Aspergillosis, eosinophilic esophagitis, and allergic rhinitis in signal transducer and activator of transcription 3 haploinsufficiency","volume":"142","author":"Natarajan","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/clim.2001.5039","article-title":"Cytokine and chemokine dysregulation in hyper-IgE syndrome","volume":"100","author":"Chehimi","year":"2001","journal-title":"Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13961408","DOI":"10.1101\/gad.1553707","article-title":"Unphosphorylated STAT3 accumulates in response to IL-6 activates transcription by binding to NF\u03baB","volume":"21","author":"Yang","year":"2007","journal-title":"Genes Dev."},{"key":"B41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.939.65.3","article-title":"Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.626593\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T20:50:52Z","timestamp":1671396652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.626593\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2021.626593"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.626593","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"article-number":"626593"}}